Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Grey

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2007
Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trialMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Clinical Endocrinology|June 6, 2007
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 yearsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 17, 2008
Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 monthsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 14, 2009
Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarctionMark J Bolland, Tom K M Wang, Niels C van Pelt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 20, 2010
Relationships between vascular calcification, calcium metabolism, bone density, and fracturesTom K M Wang, Mark J Bolland, Niels C van Pelt, et al.
Endocrinology|July 12, 2008
Modulation of osteoclastogenesis by fatty acidsJillian Cornish, Alastair MacGibbon, Jian-Ming Lin, et al.
Human Molecular Genetics|August 22, 2002
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotypeTim Cundy, Madhuri Hegde, Dorit Naot, et al.
Endocrinology|May 29, 2004
Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivoJillian Cornish, Karen E Callon, Dorit Naot, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2007
Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trialMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Clinical Endocrinology|June 6, 2007
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 yearsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 17, 2008
Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 monthsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 14, 2009
Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarctionMark J Bolland, Tom K M Wang, Niels C van Pelt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 20, 2010
Relationships between vascular calcification, calcium metabolism, bone density, and fracturesTom K M Wang, Mark J Bolland, Niels C van Pelt, et al.
Endocrinology|July 12, 2008
Modulation of osteoclastogenesis by fatty acidsJillian Cornish, Alastair MacGibbon, Jian-Ming Lin, et al.
Human Molecular Genetics|August 22, 2002
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotypeTim Cundy, Madhuri Hegde, Dorit Naot, et al.
Endocrinology|May 29, 2004
Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivoJillian Cornish, Karen E Callon, Dorit Naot, et al.
Pageof 3